Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals
Launched by UNIVERSITY OF FLORIDA · Oct 17, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to reduce the use of fall prevention alarms in hospitals. These alarms are often used to alert staff when patients are at risk of falling, but they can sometimes be overused, leading to alarm fatigue and decreased patient safety. The researchers are testing different coaching methods to help hospital staff learn better ways to prevent falls without relying too much on alarms. They will compare two different levels of coaching: low-intensity and high-intensity, to see which is more effective.
To participate in the study, you should be involved in fall prevention efforts at one of the participating hospitals that are part of the National Database of Nursing Quality Indicators (NDNQI). There are no specific age or gender requirements, so anyone who meets these criteria can be eligible. If you join the trial, you can expect to take part in educational sessions and provide feedback on your experiences, helping to improve fall prevention strategies in hospitals. Your involvement could make a real difference in keeping patients safe and reducing unnecessary alarms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stakeholders in fall prevention at up to 30 participating NDNQI hospitals
- Exclusion Criteria:
- • -
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Winfield, Illinois, United States
Flemington, New Jersey, United States
Columbus, Ohio, United States
Lubbock, Texas, United States
Warwick, Rhode Island, United States
West Bloomfield, Michigan, United States
Hillsboro, Oregon, United States
Alton, Illinois, United States
Downey, California, United States
Mountain View, California, United States
Lakeland, Florida, United States
Danville, Indiana, United States
Indianapolis, Indiana, United States
Southbridge, Massachusetts, United States
Derry, New Hampshire, United States
New Brunswick, New Jersey, United States
River Vale, New Jersey, United States
Albany, New York, United States
Uniontown, Ohio, United States
Woodburn, Oregon, United States
West Chester, Pennsylvania, United States
Irmo, South Carolina, United States
Austin, Texas, United States
Patients applied
Trial Officials
Ronald I Shorr, MD
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported